93 related articles for article (PubMed ID: 2425941)
1. Differential expression of protooncogenes related to transformation and cancer progression in rat myoblasts.
Leibovitch SA; Leibovitch MP; Guillier M; Hillion J; Harel J
Cancer Res; 1986 Aug; 46(8):4097-103. PubMed ID: 2425941
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of c-myc and decreased expression of c-fos protooncogenes in chemically and radiation-transformed C3H/10T1/2 Cl 8 mouse embryo cell lines.
Shuin T; Billings PC; Lillehaug JR; Patierno SR; Roy-Burman P; Landolph JR
Cancer Res; 1986 Oct; 46(10):5302-11. PubMed ID: 2875790
[TBL] [Abstract][Full Text] [Related]
3. Density-dependent arrest of DNA replication is accompanied by decreased levels of c-myc mRNA in myogenic but not in differentiation-defective myoblasts.
Sejersen T; Sümegi J; Ringertz NR
J Cell Physiol; 1985 Dec; 125(3):465-70. PubMed ID: 4066768
[TBL] [Abstract][Full Text] [Related]
4. Protooncogene expression in normal, preleukemic, and leukemic murine erythroid cells and its relationship to differentiation and proliferation.
Robert-Lézénès J; Meneceur P; Ray D; Moreau-Gachelin F
Cancer Res; 1988 Jul; 48(14):3972-6. PubMed ID: 3164254
[TBL] [Abstract][Full Text] [Related]
5. Amplification and expression of protooncogenes in human small cell lung cancer cell lines.
Kiefer PE; Bepler G; Kubasch M; Havemann K
Cancer Res; 1987 Dec; 47(23):6236-42. PubMed ID: 2824028
[TBL] [Abstract][Full Text] [Related]
6. Changes in gene expression following neoplastic transformation of rat myogenic cells.
Hillion J; Leibovitch SA; Leibovitch MP; Raymondjean M; Kruh J; Harel J
Cancer Res; 1984 Jul; 44(7):2959-65. PubMed ID: 6722820
[TBL] [Abstract][Full Text] [Related]
7. Elevated c-fos expression inhibits differentiation of L6 rat myoblasts.
Rahm M; Jin P; Sümegi J; Sejersen T
J Cell Physiol; 1989 May; 139(2):237-44. PubMed ID: 2469685
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of c-myc and epidermal growth factor receptor (C-erbB-1) genes in primary human renal cancer.
Yao M; Shuin T; Misaki H; Kubota Y
Cancer Res; 1988 Dec; 48(23):6753-7. PubMed ID: 2460228
[TBL] [Abstract][Full Text] [Related]
9. Suppression of tumorigenicity in somatic cell hybrids does not involve quantitative changes in transcription of cellular Ha-ras, Ki-ras, myc, and fos oncogenes.
Schäfer R; Geisse S; Willecke K
J Cell Biochem; 1987 May; 34(1):31-8. PubMed ID: 3584261
[TBL] [Abstract][Full Text] [Related]
10. [2 malignant cell lines derived from strain L6 of rat myogenic cells].
Hillion J; Leibovitch MP; Leibovitch SA; Harel J
Bull Cancer; 1982; 69(5):413-9. PubMed ID: 6187400
[TBL] [Abstract][Full Text] [Related]
11. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
12. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
13. Expression of two c-fms-related gene products in rat muscular stem cells.
Leibovitch SA; Leibovitch MP; Guillier M; Harel J
Oncogene Res; 1988 Feb; 2(3):293-8. PubMed ID: 2966925
[TBL] [Abstract][Full Text] [Related]
14. Expression of oncogenes in normal and transformed murine B lymphocytes.
DeCino P; Lernhardt W; Herbst H; Raschke WC
Oncogene Res; 1988; 3(1):33-7. PubMed ID: 3264606
[TBL] [Abstract][Full Text] [Related]
15. c-Ha-rasEJ transfection of rat aortic smooth muscle cells induces epidermal growth factor responsiveness and characteristics of a malignant phenotype.
Sadhu DN; Lundberg MS; Burghardt RC; Ramos KS
J Cell Physiol; 1994 Dec; 161(3):490-500. PubMed ID: 7962130
[TBL] [Abstract][Full Text] [Related]
16. Expression of extracellular matrix genes in relation to myogenesis and neoplastic transformation.
Leibovitch SA; Hillion J; Leibovitch MP; Guillier M; Schmitz A; Harel J
Exp Cell Res; 1986 Oct; 166(2):526-34. PubMed ID: 2427350
[TBL] [Abstract][Full Text] [Related]
17. Expression of cellular oncogenes in primary cells from human acute leukemias.
Mavilio F; Sposi NM; Petrini M; Bottero L; Marinucci M; De Rossi G; Amadori S; Mandelli F; Peschle C
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4394-8. PubMed ID: 3520570
[TBL] [Abstract][Full Text] [Related]
18. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
19. Repression of the CSF-1 receptor (c-fms proto-oncogene product) by antisense transfection induces G1-growth arrest in L6 alpha 1 rat myoblasts.
Borycki AG; Foucrier J; Saffar L; Leibovitch SA
Oncogene; 1995 May; 10(9):1799-811. PubMed ID: 7753556
[TBL] [Abstract][Full Text] [Related]
20. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
